BioGaia
117,8 SEK +0,26%2 investorer følger denne virksomhed
BioGaia is a biotechnology company. The company develops, markets and sells probiotic products. The products are mainly based on the bacterium Lactobacillus, which has probiotic effects. Today, the company's products are sold around the global market. Research and development are conducted via the company's external network of research institutions and clinics. The head office is located in Stockholm.
Omsætning
-
EBIT %
-
P/E
32,54
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
BIOG B
Daglig lav / høj pris
116,5 / 118,7
SEK
Markedsværdi
11,92 mia. SEK
Aktieomsætning
6,42 mio. SEK
Volumen
55 t
Seneste videoer
Finanskalender
Delårsrapport
22.10.2024
Årsrapport
12.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
EQT | 11,1 % | 8,3 % |
Fjärde AP-fonden | 7,7 % | 5,8 % |
Annwall & Rothschild | 4,2 % | 27,9 % |
Premier Miton Investors | 3,6 % | 2,7 % |
Cargill | 3,0 % | 2,2 % |
TIN Fonder | 2,7 % | 2,1 % |
Juno Selection Fund | 2,2 % | 1,6 % |
Tredje AP-Fonden | 2,1 % | 1,6 % |
AMF Aktiefond Småbolag | 1,6 % | 1,2 % |
Länsförsäkringar Småbolag Sverige | 1,1 % | 0,8 % |
ViserAlle indholdstyper
Change in the number of shares and votes in BioGaia AB (publ)
BioGaia, Audiocast with teleconference, Q2'24
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools